{"pub": "morningstar", "url": "https://morningstar.com/news/dow-jones/201909168597/health-care-down-as-traders-hedge-on-litigation-risks-health-care-roundup", "downloaded_at": "2019-09-16 23:12:10.836353+00:00", "title": "Health Care Down as Traders Hedge on Litigation Risks \u2014 Health Care Roundup", "language": "en", "text": "Health-care companies ticked down as traders hedged their bets on the outlook for opioid litigation.\n\nClosely held OxyContin maker Purdue Pharma filed for bankruptcy protection Sunday night with a partial deal aimed at resolving thousands of lawsuits filed by states and municipalities accusing it of fueling the opioid crisis.\n\nShares of another company facing litigation, Mallinckrodt, gave back some of their recent gains.\n\nDanish drug maker Lundbeck agreed to buy U.S. biotech company Alder BioPharmaceuticals, which is developing a migraine treatment, for up to $1.95 billion.\n\nWrite to Rob Curran at rob.curran@dowjones.com\n\n(END) Dow Jones Newswires\n\nSeptember 16, 2019 17:09 ET (21:09 GMT)\n\nCopyright (c) 2019 Dow Jones & Company, Inc.", "description": "", "authors": [], "top_image": "https://morningstar.com/assets/img/30241a1.png", "published_at": "2019-09-16"}